Advertisement.

GUTS Projected Dividend Yield

Fractyl Health Inc ( NASDAQ : GUTS )

Fractyl Health is a metabolic therapeutics company focused on the treatment of metabolic diseases. Co.'s lead product candidate, the Revita DMR System, is an outpatient procedural therapy designed to durably modify duodenal dysfunction and repeatable metabolic improvement via hydrothermal ablation of the dysfunctional duodenal mucosa to address duodenal pathology and consequent metabolic disease progression directly. Co. is also developing Rejuva, a locally administered, adeno-associated virus delivered pancreatic gene therapy platform designed to enable long-term remission of type 2 diabetes and obesity by durably altering metabolic hormone function in the pancreatic islet cells.

20 YEAR PERFORMANCE RESULTS

GUTS Dividend History Detail
GUTS Dividend News
GUTS Competitors News

# of Shares: 0

Closing Price: 2.04

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000